Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,257 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors

NCT00455052

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • TGen Clinical Research Services at Scottsdale Healthcare Scottsdale, Arizona, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Central Indiana Cancer Centers Indianapolis, Indiana, United States
  • University of Maryland, Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

NCT01460134

Conditions
Adenocarcinoma, Adnexal Diseases, Any T-cell Malignancy, +70 more
Locations
  • Mayo Clinic Arizona - Cancer Clinical Research Unit Scottsdale, Arizona, United States
  • Stanford Cancer Center - Stanford University Stanford, California, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine New York, United States
View Trial Details
Completed

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

NCT00553462

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations
  • East Bay Radiation Oncology Center Castro Valley, California, United States
  • Valley Medical Oncology Consultants - Castro Valley Castro Valley, California, United States
  • Valley Medical Oncology Fremont, California, United States
  • Contra Costa Regional Medical Center Martinez, California, United States
View all 99 locations
View Trial Details
Completed

Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

NCT00138203

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • St. Vincent Regional Cancer Center CCOP Green Bay, Wisconsin, United States
  • Gundersen Lutheran La Crosse, Wisconsin, United States
  • UW Health Oncology - 1 South Park Madison, Wisconsin, United States
  • University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States
View Trial Details
Completed

Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior Chemotherapy

NCT00364351

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Berkeley, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Boynton Beach, Florida, United States
View all 153 locations
View Trial Details
Completed

Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

NCT01486602

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Moores University of California San Diego Cancer Center La Jolla, California, United States
  • University of Chicago Chicago, Illinois, United States
View Trial Details
Completed

Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

NCT02014337

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +39 more
Locations
  • ACRC/Arizona Clinical Research Center Inc. Tucson, Arizona, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Rita Nanda, MD Chicago, Illinois, United States
View Trial Details

Related conditions